Article

Posttraumatic GABA(A)-mediated [Ca2+]i increase is essential for the induction of brain-derived neurotrophic factor-dependent survival of mature central neurons.

Institute of Biotechnology, Department of Biological and Environmental Sciences, and Neuroscience Center, University of Helsinki, FIN-00014 Helsinki, Finland.
Journal of Neuroscience (impact factor: 7.11). 08/2008; 28(27):6996-7005. DOI:10.1523/JNEUROSCI.5268-07.2008 pp.6996-7005
Source: PubMed

ABSTRACT A shift of GABA(A)-mediated responses from hyperpolarizing to depolarizing after neuronal injury leads to GABA(A)-mediated increase in [Ca2+](i). In addition, central neurons become dependent on BDNF for survival. Whether these two mechanisms are causally interrelated is an open question. Here, we show in lesioned CA3 hippocampal neurons in vitro and in axotomized corticospinal neurons in vivo that posttraumatic downregulation of the neuron-specific K-Cl cotransporter KCC2 leads to intracellular chloride accumulation by the Na-K-2Cl cotransporter NKCC1, resulting in GABA-induced [Ca2+](i) transients. This mechanism is required by a population of neurons to survive in a BDNF-dependent manner after injury, because blocking GABA(A)-depolarization with the NKCC1 inhibitor bumetanide prevents the loss of neurons on BDNF withdrawal. The resurgence of KCC2 expression during recovery coincides with loss of BDNF dependency for survival. This is likely mediated through BDNF itself, because injured neurons reverse their response to this neurotrophin by switching the BDNF-induced downregulation of KCC2 to upregulation.

0 0
 · 
0 Bookmarks
 · 
36 Views

Keywords

axotomized corticospinal neurons
 
BDNF dependency
 
BDNF-dependent manner
 
BDNF-induced downregulation
 
depolarizing
 
GABA(A)-depolarization
 
GABA(A)-mediated responses
 
intracellular chloride accumulation
 
KCC2
 
KCC2 expression
 
lesioned CA3 hippocampal neurons
 
Na-K-2Cl cotransporter NKCC1
 
neuron-specific K-Cl cotransporter KCC2
 
neuronal injury
 
neurons reverse
 
neurotrophin
 
NKCC1 inhibitor bumetanide
 
open question
 
resurgence
 
vivo